| EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ... Science 338 (6113), 1465-1469, 2012 | 993 | 2012 |
| Genomic hallmarks and structural variation in metastatic prostate cancer DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ... Cell 174 (3), 758-769. e9, 2018 | 729 | 2018 |
| Genomic hallmarks of localized, non-indolent prostate cancer M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ... Nature 541 (7637), 359-364, 2017 | 647 | 2017 |
| Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer S Shu, CY Lin, HH He, RM Witwicki, DP Tabassum, JM Roberts, ... Nature 529 (7586), 413-417, 2016 | 645 | 2016 |
| LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade W Sheng, MW LaFleur, TH Nguyen, S Chen, A Chakravarthy, JR Conway, ... Cell 174 (3), 549-563. e19, 2018 | 616 | 2018 |
| Nucleosome dynamics define transcriptional enhancers HH He, CA Meyer, H Shin, ST Bailey, G Wei, Q Wang, Y Zhang, K Xu, ... Nature genetics 42 (4), 343-347, 2010 | 566 | 2010 |
| Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1 C Cai, HH He, S Chen, I Coleman, H Wang, Z Fang, S Chen, PS Nelson, ... Cancer cell 20 (4), 457-471, 2011 | 521 | 2011 |
| 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC N Ahmadiyeh, MM Pomerantz, C Grisanzio, P Herman, L Jia, V Almendro, ... Proceedings of the National academy of sciences 107 (21), 9742-9746, 2010 | 451 | 2010 |
| Widespread and functional RNA circularization in localized prostate cancer S Chen, V Huang, X Xu, J Livingstone, F Soares, J Jeon, Y Zeng, JT Hua, ... Cell 176 (4), 831-843. e22, 2019 | 386 | 2019 |
| Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy SK Rehman, J Haynes, E Collignon, KR Brown, Y Wang, AML Nixon, ... Cell 184 (1), 226-242. e21, 2021 | 373 | 2021 |
| GlcNAcylation of histone H2B facilitates its monoubiquitination R Fujiki, W Hashiba, H Sekine, A Yokoyama, T Chikanishi, S Ito, Y Imai, ... Nature, 2011 | 352 | 2011 |
| Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing T Fei, Y Chen, T Xiao, W Li, L Cato, P Zhang, MB Cotter, M Bowden, ... Proceedings of the National Academy of Sciences 114 (26), E5207-E5215, 2017 | 332 | 2017 |
| Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development Y Xu, C Xu, A Kato, W Tempel, JG Abreu, C Bian, Y Hu, D Hu, B Zhao, ... Cell 151 (6), 1200-1213, 2012 | 321 | 2012 |
| Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression S Chen, G Zhu, Y Yang, F Wang, YT Xiao, N Zhang, X Bian, Y Zhu, Y Yu, ... Nature cell biology 23 (1), 87-98, 2021 | 315 | 2021 |
| Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19 JT Hua, M Ahmed, H Guo, Y Zhang, S Chen, F Soares, J Lu, S Zhou, ... Cell 174 (3), 564-575. e18, 2018 | 314 | 2018 |
| The DNA methylation landscape of advanced prostate cancer SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ... Nature genetics 52 (8), 778-789, 2020 | 283 | 2020 |
| Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification HH He, CA Meyer, SS Hu, MW Chen, C Zang, Y Liu, PK Rao, T Fei, H Xu, ... Nature methods 11 (1), 73-78, 2014 | 279 | 2014 |
| Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2 MP Verzi, H Shin, HH He, R Sulahian, CA Meyer, RK Montgomery, ... Developmental cell 19 (5), 713-726, 2010 | 238 | 2010 |
| Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer H Guo, M Ahmed, F Zhang, CQ Yao, SD Li, Y Liang, J Hua, F Soares, ... Nature genetics 48 (10), 1142-1150, 2016 | 236 | 2016 |
| RNA N6-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m6A-GLUT1-mTORC1 axis and is a therapeutic target H Chen, S Gao, W Liu, CC Wong, J Wu, J Wu, D Liu, H Gou, W Kang, ... Gastroenterology 160 (4), 1284-1300. e16, 2021 | 232 | 2021 |
Myles BrownEmil Frei III Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical SchoolVerified email at dfci.harvard.edu